Differential transcriptional control of hematopoiesis in congenital and cyclic neutropenia patients harboring ELANE mutations

Haematologica. 2024 May 1;109(5):1393-1402. doi: 10.3324/haematol.2023.284033.

Abstract

Mutations in the ELANE gene, encoding the neutrophil elastase (NE) protein, are responsible for most cyclic neutropenia (CyN) cases and approximately 25% of congenital neutropenia (CN) cases. In CN and in CyN, a median of 2.8% of CD34+ cells were early CD49f+ hematopoietic stem cells (eHSC) that did not express ELANE and thus escape from the unfolded protein response (UPR) caused by mutated NE. In CyN, the CD49f+ cells respond to granulocyte colony-stimulating factor (G-CSF) with a significant upregulation of the hematopoietic stem cell-specific transcription factors, C/EBPα, MLL1, HOXA9, MEIS1, and HLF during the ascending arm of the cycle, resulting in the differentiation of myeloid cells to mature neutrophils at the cycle peak. However, NE protein released by neutrophils at the cycle's peak caused a negative feedback loop on granulopoiesis through the proteolytic digestion of G-CSF. In contrast, in CN patients, CD49f+ cells failed to express mRNA levels of HSC-specific transcription factors mentioned above. Rescue of C/EBPα expression in CN restored granulopoiesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Congenital Bone Marrow Failure Syndromes / genetics
  • Congenital Bone Marrow Failure Syndromes / pathology
  • Female
  • Gene Expression Regulation
  • Granulocyte Colony-Stimulating Factor / metabolism
  • Hematopoiesis* / genetics
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / metabolism
  • Humans
  • Leukocyte Elastase* / genetics
  • Leukocyte Elastase* / metabolism
  • Male
  • Mutation*
  • Neutropenia* / congenital
  • Neutropenia* / genetics
  • Neutropenia* / metabolism
  • Neutrophils / metabolism
  • Transcription, Genetic

Substances

  • Leukocyte Elastase
  • ELANE protein, human
  • Granulocyte Colony-Stimulating Factor

Supplementary concepts

  • Cyclic neutropenia

Grants and funding

Funding: This work was supported by the Intramural Fortüne program of the Medical Faculty of the UKT (to MK, AZ), Madeleine Schickedanz Kinderkrebsstiftung (to JS, KW, MK, MN), DFG (to JS, AZ), BMBF (to JS, KW, CZ, SK), and the COST Action European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (EuNet-INNOCHRON) (to KW, CZ, MK, JS). We acknowledge the support by the Open Access Publishing Fund of the University of Tübingen.